IRIS
MAZZINI, LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.709
NA - Nord America 3.358
AS - Asia 3.170
SA - Sud America 500
AF - Africa 190
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 11.936
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.235
RU - Federazione Russa 1.329
SG - Singapore 1.148
IE - Irlanda 855
CN - Cina 661
IT - Italia 655
DE - Germania 491
HK - Hong Kong 448
VN - Vietnam 424
BR - Brasile 379
SE - Svezia 369
FR - Francia 225
UA - Ucraina 216
FI - Finlandia 137
GB - Regno Unito 126
BJ - Benin 101
IN - India 95
KR - Corea 94
CA - Canada 62
PL - Polonia 48
JP - Giappone 45
AR - Argentina 43
NL - Olanda 42
AT - Austria 41
ID - Indonesia 38
MX - Messico 38
ZA - Sudafrica 38
BD - Bangladesh 37
TR - Turchia 36
CZ - Repubblica Ceca 29
IQ - Iraq 28
IR - Iran 27
ES - Italia 25
BE - Belgio 24
EE - Estonia 24
LT - Lituania 17
EC - Ecuador 16
DK - Danimarca 15
CL - Cile 14
CO - Colombia 13
JO - Giordania 13
DZ - Algeria 12
PY - Paraguay 12
RO - Romania 12
AE - Emirati Arabi Uniti 10
DO - Repubblica Dominicana 8
MA - Marocco 8
PK - Pakistan 8
TN - Tunisia 8
PE - Perù 7
PH - Filippine 7
VE - Venezuela 7
CH - Svizzera 6
TH - Thailandia 6
UZ - Uzbekistan 6
GR - Grecia 5
KE - Kenya 5
SA - Arabia Saudita 5
AU - Australia 4
AZ - Azerbaigian 4
BO - Bolivia 4
JM - Giamaica 4
NP - Nepal 4
PA - Panama 4
UY - Uruguay 4
EG - Egitto 3
EU - Europa 3
MY - Malesia 3
PS - Palestinian Territory 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AO - Angola 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GD - Grenada 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
PT - Portogallo 2
SI - Slovenia 2
SN - Senegal 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CM - Camerun 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
Totale 11.925
Salva come PNG Salva come JPEG
Città #
Dublin 851
Hong Kong 443
Singapore 418
Jacksonville 349
San Jose 321
Ashburn 288
Beijing 261
Moscow 160
Dearborn 157
Ho Chi Minh City 137
Los Angeles 134
Lauterbourg 129
Chandler 122
Cotonou 101
Seoul 91
Hanoi 78
Munich 76
Buffalo 72
Lawrence 72
Princeton 72
Novara 71
Wilmington 70
Piemonte 61
New York 57
Dallas 50
San Mateo 50
Ann Arbor 49
Bremen 48
Orem 48
Turin 47
Rome 45
São Paulo 44
Helsinki 43
Milan 39
Boardman 36
Frankfurt am Main 35
Mülheim 34
Santa Clara 33
Warsaw 33
Houston 32
Tokyo 32
Falkenstein 31
Nuremberg 29
Brno 24
Stockholm 24
Strasbourg 24
Brooklyn 23
Chennai 23
Johannesburg 23
Redondo Beach 23
The Dalles 23
Denver 22
Montreal 21
Vienna 21
Amsterdam 19
London 19
Toronto 19
Brussels 18
Council Bluffs 18
Phoenix 18
Tianjin 18
Andover 17
Mexico City 17
Nanjing 17
Atlanta 16
Chicago 15
Jakarta 15
Rio de Janeiro 15
Vercelli 15
Ankara 14
Da Nang 14
Hải Dương 14
Manchester 14
Monmouth Junction 14
Turku 14
Woodbridge 14
Guangzhou 13
Haiphong 13
Poplar 13
Zanjan 13
Amman 12
Boston 12
Hillsboro 12
Seattle 12
Baghdad 10
Biên Hòa 10
Kunming 10
Quận Bình Thạnh 10
Villadossola 10
Hangzhou 9
Kocmyrzów 9
Curitiba 8
Hefei 8
Kocaeli 8
Leawood 8
Ottawa 8
Roubaix 8
Belo Horizonte 7
Borgomanero 7
Bắc Ninh 7
Totale 6.191
Salva come PNG Salva come JPEG
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 240
Retrospective observational study on the use of acetyl-L-carnitine in ALS 187
Advances in stem cell therapy for amyotrophic lateral sclerosis 172
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 156
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 148
Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine: A Population-Based Study. 147
Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis 140
Human neural stem cell transplantation in ALS: initial results from a phase I trial. 135
The First Case of the TARDBP p.G294V Mutation in a Homozygous State: Is a Single Pathogenic Allele Sufficient to Cause ALS? 132
Coeliac disease mimicking Amyotrophic Lateral Sclerosis. 127
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study 126
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 125
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 124
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 124
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways 123
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 121
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 119
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 117
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 116
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 114
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis 114
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 114
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 111
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 111
Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis 110
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 110
Extensive genetics of ALS: a population-based study in Italy. 109
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 108
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 107
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 107
The multistep hypothesis of ALS revisited: The role of genetic mutations 107
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 107
A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient 106
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 106
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 106
null 105
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 104
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations 100
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 98
Cognitive impairment across ALS clinical stages in a population-based cohort 98
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 96
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 95
Autologous Stem Cells Transplantation in Amyotrophic Lateral Sclerosis: A Phase I Clinical Trial 95
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 94
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 94
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 93
Transplantation of mesenchymal stem cells in ALS. 93
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 93
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 93
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 92
Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. 92
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 90
A rare case of conjugal amyotrophic lateral sclerosis. 90
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 89
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 88
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. 88
Circulating GLAST+ EVs are increased in amyotrophic lateral sclerosis 86
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 86
Authors' response to a letter from Dr. Esquinas. 86
ATXN-2 CAG repeat expansions are interrupted in ALS patients 86
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 84
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 83
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 83
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 81
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 80
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 79
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 79
SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS) 79
C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. 79
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 78
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis 78
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 78
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 77
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 77
Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population 77
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population 76
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis 76
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis 74
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. 73
VPS54 genetic analysis in ALS Italian cohort 73
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 73
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 73
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 72
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 71
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 71
Non-invasive ventilation after surgery in amyotrophic lateral sclerosis 71
Long-term survival of participants in a phase II randomized trial of RNS60 in amyotrophic lateral sclerosis 70
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 70
Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study 70
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 70
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 69
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 69
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 69
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 67
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 67
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 66
GBA variants influence cognitive status in amyotrophic lateral sclerosis 66
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 65
Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond 65
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 65
Totale 9.693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202195 0 0 0 0 0 0 0 0 0 13 74 8
2021/2022594 33 10 57 70 27 10 19 14 46 18 152 138
2022/20231.702 87 84 61 25 112 121 53 81 927 21 92 38
2023/2024644 59 41 78 33 101 20 94 9 11 7 60 131
2024/20252.099 45 44 122 44 39 235 136 212 405 207 171 439
2025/20265.624 327 255 392 844 700 462 841 1.010 419 374 0 0
Totale 12.191